Literature DB >> 19143015

Delineating melanoma using multimodal polarized light imaging.

Zeina Tannous1, Munir Al-Arashi, Sonali Shah, Anna N Yaroslavsky.   

Abstract

BACKGROUND AND SIGNIFICANCE: Melanoma accounts for 3% of all skin cancers but causes 83% of skin cancer deaths. The first step in treatment of melanoma is the removal of the lesions, usually by surgical excision. Currently most lesions are removed without intraoperative margin control. Post-operative methods inspect 1-2% of the surgical margin and are prone to sampling errors. In this study we evaluate the use of reflectance and fluorescence polarization imaging for the demarcation of melanoma in thick fresh skin excisions.
MATERIALS AND METHODS: Pigmented lesions clinically suspicious for melanoma were elliptically excised with proper margins. Elliptical surgical excisions were vertically bisected along the short axis of the specimen into two halves in the middle of the pigmented lesions. The vertically bisected tumor face was imaged. After that, one half of the sample was briefly stained in aqueous 2 mg/ml solution of tetracycline, whereas another half was stained in 0.2 mg/ml aqueous solution of methylene blue. Then both specimens were reimaged. Reflectance images were acquired in the spectral range between 390 and 750 nm. Fluorescence images of the tetracycline-stained tissue were excited at 390 nm and registered between 450 and 700 nm. Fluorescence of the methylene blue-stained samples was excited at 630 nm and registered between 650 and 750 nm. After imaging, the tissue was processed for standard H&E histopathology. The resulting histological and optical images were compared to each other. RESULTS AND
CONCLUSIONS: Our findings demonstrate that both tetracycline and methylene blue are suitable for imaging dysplastic and benign nevi. Melanoma is better delineated in the samples stained in methylene blue. Accurate and rapid delineation of melanoma in standard fresh surgical excisions appears feasible.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19143015     DOI: 10.1002/lsm.20736

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  5 in total

1.  Dye-enhanced multimodal confocal microscopy for noninvasive detection of skin cancers in mouse models.

Authors:  Jesung Park; Pawel Mroz; Michael R Hamblin; Anna N Yaroslavsky
Journal:  J Biomed Opt       Date:  2010 Mar-Apr       Impact factor: 3.170

2.  Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies.

Authors:  Larissa Sweeny; Andrew Prince; Neel Patel; Lindsay S Moore; Eben L Rosenthal; Brian B Hughley; Jason M Warram
Journal:  Laryngoscope       Date:  2016-08-31       Impact factor: 3.325

3.  Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma.

Authors:  Kristine E Day; Lauren N Beck; Nicholas L Deep; Joy Kovar; Kurt R Zinn; Eben L Rosenthal
Journal:  Laryngoscope       Date:  2013-04-24       Impact factor: 3.325

4.  Reflectance confocal microscopy for diagnosing cutaneous melanoma in adults.

Authors:  Jacqueline Dinnes; Jonathan J Deeks; Daniel Saleh; Naomi Chuchu; Susan E Bayliss; Lopa Patel; Clare Davenport; Yemisi Takwoingi; Kathie Godfrey; Rubeta N Matin; Rakesh Patalay; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2018-12-04

5.  Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults.

Authors:  Jacqueline Dinnes; Jonathan J Deeks; Naomi Chuchu; Daniel Saleh; Susan E Bayliss; Yemisi Takwoingi; Clare Davenport; Lopa Patel; Rubeta N Matin; Colette O'Sullivan; Rakesh Patalay; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2018-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.